Immunogenicity and Safety of 2 Doses of Live Attenuated Varicella Vaccine

PHASE4CompletedINTERVENTIONAL
Enrollment

716

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Varicella
Interventions
BIOLOGICAL

varicella-1

Give the second varicella vaccine (a single 0.5 ml) and get blood samples at 0, 35-42 day

BIOLOGICAL

varicella-3

Give the second varicella vaccine (a single 0.5 ml) and get blood samples at 0, 35-42 day

BIOLOGICAL

varicella-5

Give the second varicella vaccine (a single 0.5 ml) and get blood samples at 0, 35-42 day

Trial Locations (1)

Unknown

Shenzhen Luohu District Center for Disease Control and Prevention, Shenzhen

All Listed Sponsors
collaborator

Guangdong Provincial Institute of Biological Products And Materia Medica

OTHER

lead

Changchun Keygen Biological Products Co., Ltd.

OTHER

NCT02173899 - Immunogenicity and Safety of 2 Doses of Live Attenuated Varicella Vaccine | Biotech Hunter | Biotech Hunter